Johan M. Spoor

CIK: 0001535289

Transaction Breakdown

Open Market Buys (P)6 (75.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CATX

Perspective Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

CATX
Perspective Therapeutics, Inc.
Mar 2, 2026
Award(A)
Stock option (right to buy)
Direct
735K shares-
CATX
Perspective Therapeutics, Inc.
Mar 28, 2025
Purchase(P)
Direct
22K shares at avg. $2.24$49K
CATX
Perspective Therapeutics, Inc.
Mar 28, 2025
Purchase(P)
Indirect
4.7K shares at avg. $2.21$10K
CATX
Perspective Therapeutics, Inc.
Mar 3, 2025
Award(A)
Stock option (right to buy)
Direct
650K shares-
CATX
Perspective Therapeutics, Inc.
Dec 4, 2024
Purchase(P)
Direct
8K shares at avg. $3.77$30K
CATX
Perspective Therapeutics, Inc.
Nov 25, 2024
Purchase(P)
Direct
14.5K shares at avg. $3.78$55K
CATX
Perspective Therapeutics, Inc.
Nov 25, 2024
Purchase(P)
Indirect
5.4K shares at avg. $3.80$21K
CATX
Perspective Therapeutics, Inc.
Nov 25, 2024
Purchase(P)
Indirect
6.6K shares at avg. $3.80$25K

		Type	Shares	Price		Ownership
Mar 2, 2026	CATX Perspective Therapeutics, Inc.	Award(A) Stock option (right to buy)	735,000	-	-	Direct
Mar 28, 2025	CATX Perspective Therapeutics, Inc.	Purchase(P)	22,026	$2.24	$49,384	Direct
Mar 28, 2025	CATX Perspective Therapeutics, Inc.	Purchase(P)	4,650	$2.21	$10,288	Indirect
Mar 3, 2025	CATX Perspective Therapeutics, Inc.	Award(A) Stock option (right to buy)	650,000	-	-	Direct
Dec 4, 2024	CATX Perspective Therapeutics, Inc.	Purchase(P)	8,000	$3.77	$30,132	Direct
Nov 25, 2024	CATX Perspective Therapeutics, Inc.	Purchase(P)	14,500	$3.78	$54,868	Direct
Nov 25, 2024	CATX Perspective Therapeutics, Inc.	Purchase(P)	5,400	$3.80	$20,520	Indirect
Nov 25, 2024	CATX Perspective Therapeutics, Inc.	Purchase(P)	6,600	$3.80	$25,080	Indirect

1-8 of 8 transactions

About Spoor Johan M.

Spoor Johan M. (SEC CIK 0001535289) files insider reports with the SEC as Chief Executive Officer of Perspective Therapeutics, Inc. (CATX).

Signal8 holds 6 ownership filings by Spoor Johan M., all Form 4s, filed between Nov 26, 2024 and Mar 4, 2026. Those filings report 8 transactions, from Nov 25, 2024 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Spoor Johan M.'s filings is in SEATTLE, WA.

Recent filings by Spoor Johan M.

Mar 2, 2026: Grant or award of CATX derivative securities (Form 4, code A).
Mar 28, 2025: Open-market purchases of CATX shares (2 lines, Form 4, code P).
Mar 3, 2025: Grant or award of CATX derivative securities (Form 4, code A).
Dec 4, 2024: Open-market purchase of CATX shares (Form 4, code P).
Nov 25, 2024: Open-market purchases of CATX shares (3 lines, Form 4, code P).

Other insiders filing for Perspective Therapeutics, Inc. (CATX)

How to read Form 4 transaction codes